Article

Beckman Coulter Life Sciences has partnered with London-based Automata to integrate its liquid handling and cell analysis technologies with Automata's AI-ready automation platform. This collaboration aims to enhance experimentation speed and scalability for research organizations.

The integration will occur within Automata's LINQ automation ecosystem, which features intelligent robotics, unified scheduling software, and flexible workflow design. The partnership also includes Danaher Corporation's investment in Automata's Series C funding round, with Danaher Ventures joining Automata's board to support future innovation.